Peptide Medix product catalog

Research Peptides · Cat. 035-33

INSL4 / EPIL (Human)

Supplied as 100 µg per unit. Purity ≥ 95%. Molecular weight 7329.48. Species: Human. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.

Specifications

Catalog number035-33
Product typeResearch Peptides
Peptide familyInsulin-Like Peptide 4 (INSL4)
SpeciesHuman
Unit size100 µg
Molecular weight7329.48 Da
Purity≥ 95%
ValidationExhibits correct molecular weight
AppearanceWhite powder
ContentsEach vial contains 100 µg of NET peptide.
B-ChainpGlu-Leu-Leu-Arg-Glu-Ser-Leu-Ala-Ala-Glu-Leu-Arg-Gly-Cys-Gly-Pro-Arg-Phe-Gly-Lys-His-Leu-Leu-Ser-Tyr-Cys-Pro-Met-Pro-Glu-Lys-Thr-Phe-Thr-Thr-Thr-Pro-Gly-Gly-Trp-Leu
SolubilitySoluble in water
Disulfide BridgeDisulfide bridge(s): CysA10-CysA15, CysA11-CysB14, CysA24-CysB26 The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. El-shewy HM, Lee MH, Obeid LM, Jaffa AA, Luttrell LM. J Biol Chem. 2007;282(36):26150-7. Insulin-like peptide 5: expression in the mouse brain and mobilization of calcium. Dun SL, Brailoiu E, Wang Y, et al. Endocrinology. 2006;147(7):3243-8. Identification of relaxin-3/INSL7 as a ligand for GPCR142. Liu C, Chen J, Sutton S, et al. J Biol Chem. 2003;278(50):50765-70.
Research topicsCancer Research
Intended useIn vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes

Sequence

Ser-Gly-Arg-His-Arg-Phe-Asp-Pro-Phe-Cys-Cys-Glu-Val-Ile-Cys-Asp-Asp-Gly-Thr-Ser-Val-Lys-Leu-Cys-Thr

25 residues · MW 7329.48

Storage & handling

Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.

Confirm handling and preparation requirements against current product documentation and the requirements of your laboratory protocol.

Frequently asked

What is INSL4 / EPIL (Human)?
INSL4 / EPIL (Human) is a research peptide listed under catalog number 035-33 in the Insulin-Like Peptide 4 (INSL4) family, human sequence. It is supplied as 100 µg per unit for in vitro laboratory research.
What purity is listed for 035-33?
The imported catalog record lists ≥ 95% (exhibits correct molecular weight). Request and verify current lot-specific documentation before purchase.
How should INSL4 / EPIL (Human) be stored?
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
What is the sequence of INSL4 / EPIL (Human)?
The 25-residue sequence is Ser-Gly-Arg-His-Arg-Phe-Asp-Pro-Phe-Cys-Cys-Glu-Val-Ile-Cys-Asp-Asp-Gly-Thr-Ser-Val-Lys-Leu-Cys-Thr, molecular weight 7329.48.
What is the intended use of 035-33?
This catalog listing is for laboratory research use only. It is not represented as a drug, food, supplement, cosmetic or diagnostic product, and it is not offered for human or veterinary use.

This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.